Premium
Ticagrelor: novel antithrombotic for acute coronary syndromes
Author(s) -
Chaplin Steve,
Storey Robert F
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.827
Subject(s) - medicine , ticagrelor , antithrombotic , acute coronary syndrome , adverse effect , cardiology , intensive care medicine , myocardial infarction
Ticagrelor (Brilique) is an oral, reversible platelet inhibitor licensed to prevent atherothrombotic events in acute coronary syndromes. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Professor Storey discusses its place in the treatment of acute coronary syndromes. Copyright © 2011 Wiley Interface Ltd